Brief: Ginkgo Bioworks And Xwell Implement Expand CDC Traveler-Based Genomic Surveillance Program To Test For More Than 30 Known Pathogens
06/11/2023 12:12
Nov 6 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* GINKGO BIOWORKS AND XWELL IMPLEMENT EXPANDED CDC
TRAVELER-BASED
GENOMIC SURVEILLANCE PROGRAM TO TEST FOR MORE THAN 30 KNOWN
PATHOGENS
Source text for Eikon: ID:nGNXQcB60
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XWELL
See all newsMedia: Trump family-linked American Ventures backs XWell, a spa company offering medical screening- FT
Brief: Xwell Registers Resale Of Up To 138.7 Million Shares Of Common Stock From Time To Time By Selling Stockholders - SEC Filing
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 09:57 AM